Meeting
2022 ASCO Annual Meeting
Phase III randomized control study evaluating adjuvant metronomic chemotherapy in locally advanced head and neck cancers post-radical chemoradiation (MACE-CTRT).
Authors
Sunil Ramdhan Chopade
Tata Memorial, Mumbai, India
Sunil Ramdhan Chopade , Vijay Maruti Patil , Vanita Noronha , Nandini Sharrel Menon , Atanu Bhattacharjee , Kavita Prakash Nawale , Shripad Dinanath Banavali , Kumar Prabhash , Vijayalakshmi Mathrudev
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Head and Neck Cancer
Track
Head and Neck Cancer
Sub Track
Local-Regional Disease
Clinical Trial Registration Number
CTRI/2016/09/007315
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 6073)
DOI
10.1200/JCO.2022.40.16_suppl.6073
Abstract #
6073
Poster Bd #
65
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
A retrospective analysis of patients administered neoadjuvant chemotherapy (NACT) with paclitaxel plus carboplatin with oral metronomic chemotherapy (OMCT) in locally advanced borderline resectable/technically unresectable head and neck cancers.
First Author: Shruti Pathak
Poster
2014 ASCO Annual Meeting
A phase II study comparing metronomic chemotherapy with chemotherapy (single-agent cisplatin), in patients with metastatic, relapsed, or inoperable squamous cell carcinoma of head and neck.
First Author: Vijay Maruti Patil
Poster
2022 ASCO Annual Meeting
Nimotuzumab plus concurrent chemo-radiotherapy versus chemo-radiotherapy in unresectable locally advanced esophageal squamous cell carcinoma (ESCC): Interim analysis from a prospective, randomized-controlled, double-blinded, multicenter, and phase III clinical trial (NXCEL1311 Study).
First Author: Xue Meng
Poster
2022 ASCO Annual Meeting
Phase 3 randomised study evaluating the addition of low-dose nivolumab to palliative chemotherapy in head and neck cancer.
First Author: Vijay Maruti Patil